期刊文献+

左卡尼汀干预癌性恶液质能量代谢 被引量:2

L-carnitine intervention in energy metabolism of cancer cachexia patients
下载PDF
导出
摘要 目的癌性恶液质患者左旋肉碱水平低下,能量代谢异常,本文探讨左卡尼汀对癌性恶液质能量代谢的影响。方法回顾近年来国内外发表的有关左卡尼汀和癌性恶液质、能量代谢的中英文文献,并进行综合评述。结果左卡尼汀能够纠正恶液质患者脂质代谢紊乱,通过调节下丘脑脂肪酸代谢而改善恶液质者厌食;显著降低蛋白质代谢相关蛋白酶体活性,抑制蛋白质水解,改善患者一般情况,改善乏力;改善胰岛素抵抗,提高胰岛素敏感性。结论左卡尼汀干预癌性恶液质能量代谢值得关注,但尚需大样本研究证据证实,潜在机制也需要进一步深入研究。 Objective As cancer cachexia patients present low level of L-carnitine and abnormal energy metabolism, this study is to evaluate the impact of L-carnitine on energy metabolism of cancer cachexia patients. Methods We collected and analysed the results from the domestic and foreign published literature related to L-carnitine, cancer cachexia and energy metabolism in recent years. Results L-carnitine can ameliorate lipid metabolism disorders in cachexia patients, ameliorate anorexia by adjusting fatty acid metabolism in the hypothalamus;signiifcantly decrease activities of proteasome related with protein metabolism, inhibit proteolysis, improve performance status and fatigue of patients;improve insulin resistance and increase insulin sensitivity. Conclusions The intervention of L-carnitine in cancer cachexia is worth paying attention to, but still need large sample research evidence to conifrm, its underlying mechanisms also need further research.
作者 吴丹 李苏宜
出处 《肿瘤代谢与营养电子杂志》 2016年第1期58-62,共5页 Electronic Journal of Metabolism and Nutrition of Cancer
基金 安徽省自然科学基金(1508085MH176)
关键词 左卡尼汀 癌性恶液质 能量代谢 L-carnitine Cancer cachexia Energy metabolism
  • 相关文献

参考文献30

  • 1Cachexia in pancreatic cancer – Mechanisms and potential intervention(J)e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism . 2009 (6)
  • 2Argiles JM,Busquets S,Stemmler B,et al.Cancer cachexia:understanding the molecular basis. Nature Reviews Cancer . 2014
  • 3von Haehling Stephan,Anker Stefan D.Cachexia as a major underestimated and unmet medical need: facts and numbers. Journal of cachexia, sarcopenia and muscle . 2011
  • 4Luigi G Spagnoli,Giampiero Palmieri,Alessandro Mauriello,Gian Maria Vacha,Stefania D’Iddio,Giovanni Giorcelli,Marco Corsi.Morphometric Evidence of the Trophic Effect of L-Carnitine on Human Skeletal Muscle. Nephron . 1990
  • 5Giovenali P,Fenocchio D,Montanari G,Cancellotti C,D’Iddio S,Buoncristiani U,Pelagaggia M,Ribacchi R.Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney International . 1994
  • 6Beshlawy Amal El,Abd El Dayem Soha M,Mougy Fatma El,Gafar Esmat Abd El,Samir Hend.Screening of growth hormone deficiency in short thalassaemic patients and effect of L-carnitine treatment. Archives of medical science : AMS . 2010
  • 7R A CRUCIANI,E DVORKIN,P HOMEL,B CULLINEY,S MALAMUD,L SHAIOVA,S FLEISHMAN,J LAPIN,E KLEIN,P LESAGE,R PORTENOY,N ESTEBAN-CRUCIANI.l-Carnitine Supplementation for the Treatment of Fatigue and Depressed Mood in Cancer Patients with Carnitine Deficiency: A Preliminary Analysis. Annals of the New York Academy of Sciences . 2004
  • 8Keller Janine,Ringseis Robert,Priebe Steffen,Guthke Reinhard,Kluge Holger,Eder Klaus.Dietary L-carnitine alters gene expression in skeletal muscle of piglets. Molecular nutrition & food research . 2010
  • 9Sílvia Busquets,Roberto Serpe,Míriam Toledo,Angélica Betancourt,Enrica Marmonti,Marcel Orpí,Fabrizio Pin,Eva Capdevila,Clelia Madeddu,Francisco J. López-Soriano,Giovanni Mantovani,Antonio Macciò,Josep M. Argilés.l -Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer[J].Clinical Nutrition.2012(6)
  • 10N. Johns,N.A. Stephens,K.C.H. Fearon.??Muscle wasting in cancer(J)International Journal of Biochemistry and Cell Biology . 2013

二级参考文献40

  • 1赵艳凤,姜达.癌性恶病质发生的分子机制及其逆转[J].实用肿瘤学杂志,2007,21(2):169-172. 被引量:13
  • 2梁艳,陈充抒.甲孕酮治疗癌症恶病质的疗效[J].中国药师,2007,10(6):573-574. 被引量:1
  • 3[1]De Wyes WD,Herbst SH.Oral feeding in the nutritional management of the cancer patient.Cancer Res 1977; 37:2429-2431
  • 4[2]Maltoni M,Nanni O,Pirovano M,Scarpi E,Indelli M,Martini C,Monti M,Arnoldi E,Piva L,Ravaioli A,Cruciani G,Labianca R,Amadori D.Successful validation of the palliative prognostic score in terminally ill cancer patients.Italian Multicenter Study Group on Palliative Care.J Pain Symptom Manage 1999; 17:240-247
  • 5[3]Bruera E,Sweeney C.Cachexia and asthenia in cancer patients.Lancet Oncol 2000; 1:138-147
  • 6[4]Pezner R,Archambeau JO.Critical evaluation of the role of nutritional support for radiation therapy patients.Cancer 1985;55:263-267
  • 7[5]Kahler A,Zimmermann M,Langhans W.Suppression of hepatic fatty acid oxidation and food intake in men.Nutrition1999; 15:819-828
  • 8[6]Loftus TM,Jaworsky DE,.Frehywot GL,Townsend CA,Ronnett GV,Lane MD,Kuhajda FP.Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.Science 2000; 288:2379-2381
  • 9[7]Rebouche CJ.Quantitative estimation of absorption and degradation of a carnitine supplement by human adults.Metabolism 1991; 40:1305-1310
  • 10[8]Rebouche CJ,Chenard CA.Metabolic fate of dietary carnitine in human adults:identification and quantification of urinary and fecal metabolites.J Nutr 1991; 121:539-546

共引文献27

同被引文献32

  • 1M.C.Storm,PhD,B.Wang,MD,R.A.Helras,PharmD,牛玉坚.卡尼汀(肉毒碱)在儿科肠外营养和全营养混合液中的稳定性[J].中国临床营养杂志,2000,8(1):47-48. 被引量:2
  • 2冯一,蔡威.左卡尼汀临床应用的研究进展[J].肠外与肠内营养,2005,12(5):306-308. 被引量:14
  • 3Janos Kemer,Charles Hoppel. Generic disorders of camitine metabolism and their nutritional management[ J 1 - Annu Rev Nutr, 1998,18 : 179 - 206.
  • 4Catherine M Crill, Richard A Helms. The Use of Carnitine in Pediatric Nutrition [ 1. Nutr Clin Pract ,2007,22:204 - 213.
  • 5Pooyandjoo M, Nouhi M, Shab Bidar S, et al. The effect of ( L - ) carni- tine on weight loss in adults : a systematic review and meta- analysis of randomized controlled trials [ J ]. Obes Rev,2016,11 : 1 - 7.
  • 6Giudetti A M, Stanca E, Siculella L, et al. Nutritional and Hormonal Regulation of Citrate and Carnitine/Acylcamitine Transporters: Two Mi- tochondrial Carriers Involved in Fatty Acid Metabolism [ J ]. Int J Mol Sci,2016,17(6) :1 - 15.
  • 7Rebouche C J. Carnitine function and requirements during the life cycle [ J ]. FASEB J, 1992,6:3379 - 3386.
  • 8Anna M, Giudetti, Eleonora Stanca,et al. Nutritional and Hormonal Reg- ulation of Citrate and Carnitine/Acylcarnitine Transporters: Two Mito- chondrial Carriers Involved in Fatty Acid Metabolism [ J]. Int J Mol Sci, 2016,17:817.
  • 9Peggy R Borum. Carnitine in Parenteral Nutrition [ J ]. Gastroenterology, 2009,137 :s129 - s134.
  • 10Weaver L T, Rosenthal S R, Gladstone W, et al. Carnitine deficiency:a possible cause of gastrointestinal dysmotility[ J]. Acta Pediatr, 1992,81 : 79 - 81.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部